Acquired by CellCarta.
Biogazelle is a Ghent University spin-off founded in 2007 by Jo Vandesompele and Jan Hellemans from the Center for Medical Genetics. Since 2010, Biogazelle offers expert laboratory services in the area of gene expression analysis. To this purpose, several state-of-the-art laboratory methods such as RNA sequencing and digital PCR are being used, complemented with custom developed unique software tools, including qbase+.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
Sentea leverages silicon photonics to develop a cost-effective fiber optic sensor interrogator.
Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.
